Invention Grant
- Patent Title: Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
-
Application No.: US16992188Application Date: 2020-08-13
-
Publication No.: US11559576B2Publication Date: 2023-01-24
- Inventor: Kevin A. Bray , Frank Delfino , Matthew C. Franklin , Elena S. Garnova , Jessica Kirshner , Douglas MacDonald , William Olson , Gavin Thurston
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: McCarter & English, LLP
- Agent Marcie B. J. Clarke D.; Deborah L. Nagle
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07K16/28 ; A61P31/20 ; A61P35/00 ; A61K39/00 ; C07K16/08
Abstract:
The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
Public/Granted literature
- US20220001000A1 ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF Public/Granted day:2022-01-06
Information query
